Skip to main content
. 2017 Jan 27;8(12):18914–18923. doi: 10.18632/oncotarget.14835

Figure 4. IL-17B prompted the expression of soluble factors in MSC.

Figure 4

(A and B) Quantitative analyses for relative mRNA levels of IL-17B in hucMSCs (A) and GC-MSCs(B) treated with/without 100 ng/ml and 200 ng/ml rIL-17B for 48 hours. (C and D) Quantitative analyses for relative mRNA levels of IL-6, IL-8, TGF-β and CCL-5 in hucMSCs (C) and GC-MSCs (D) treated with/without 100 ng/ml and 200 ng/ml rIL-17B for 48 hours. All samples were measured in triplicate, *p < 0.05, **p < 0.01, ***p < 0.001).